Skip to main content
logo
Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia flag Australia · Delayed Price · Currency is AUD
0.1750
0.00 (0.00%)
Aug 21, 2026, 4:15 PM AEST

ASX:PAR Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
10411989279224483
Market Cap Growth
-11.34%32.94%-67.97%24.43%-53.57%-31.80%
Enterprise Value
999456195170398
Last Close Price
0.170.300.260.960.932.03

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-14.0514.05---
PS Ratio
12301.38---2829.6423494.01
PB Ratio
17.335.613.605.205.306.17
P/TBV Ratio
20.415.724.095.505.706.41

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
----2142.5319352.81

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
1.5600.010.010.020.01
Net Debt / Equity Ratio
-0.89-0.79-0.71-1.04-0.92-0.90
Net Debt / EBITDA Ratio
0.140.730.270.940.821.63
Net Debt / FCF Ratio
0.201.050.271.241.212.01
Asset Turnover
0---0.000
Quick Ratio
1.277.177.124.855.9313.74
Current Ratio
1.317.467.514.896.0213.98
Return on Equity (ROE)
-180.22%-81.66%-149.69%-108.16%-65.10%-36.79%
Return on Assets (ROA)
-82.94%-55.11%-85.28%-63.78%-44.22%-27.38%
Return on Capital Employed (ROCE)
-592.70%-109.40%-260.30%-111.20%-111.80%-54.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-34.72%-15.80%-65.74%-18.61%-17.51%-7.10%
FCF Yield
-26.38%-13.46%-73.81%-16.20%-14.37%-7.24%
Buyback Yield / Dilution
-7.48%-7.23%-17.43%-7.34%-1.21%-14.32%